GlassScriptPhysician profile
Dalia Lorenzo
NPI 1760402820
$2,932.23
in general payments reported to CMS, 2019-2025
14 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $98.24 · 2021: $77.94 · 2022: $254 · 2023: $969 · 2024: $814 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,962.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,441.18 | 2019-2024 | Fintepla, Nayzilam, Briviact |
| Jazz Pharmaceuticals INC. | $409.21 | 2023-2025 | Epidiolex |
| Eisai INC. | $356.86 | 2019 | |
| Abbott Laboratories | $204.84 | 2021-2022 | |
| Neurelis, INC. | $183.84 | 2020-2024 | Valtoco |
| Abbvie INC. | $129.85 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $78.12 | 2022-2023 | Ponvory |
| Celgene Corporation | $24.26 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $21.74 | 2022 | |
| Neurocrine Biosciences, INC. | $18.55 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.44 | 2019 | |
| Adamas Pharmaceuticals, INC. | $17.84 | 2021 | |
| Livanova USA, INC. | $17.50 | 2020 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dalia Lorenzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.